You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (82)

Journals (0)

1-10 of 82 results for HER2-targeted agents

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: HER2-targeted agents and interstitial lung disease: A real-world pharmacovigilance analysis using FAERS data

Retricted access

Research article

First published 2025

HER2-targeted agents and interstitial lung disease: A real-world pharmacovigilance analysis using FAERS data

Huahua Zhang, Yandong Zhang, Xiaoying Wang [...]

Journal of Oncology Pharmacy Practice

Select article: 186 Re-Labeled Antibodies to p185 HER2 as HER2-Targeted Radioimmunopharmaceutical Agents: Comparison of Physical and Biological Characteristics with 125 I and 131 I-Labeled Counterparts

Retricted access

Research article

First published 1996-04

186 Re-Labeled Antibodies to p185 HER2 as HER2-Targeted Radioimmunopharmaceutical Agents: Comparison of Physical and Biological Characteristics with 125 I and 131 I-Labeled Counterparts

C.E. Kotts, F.M. Su, C. Leddy [...]

Cancer Biotherapy and Radiopharmaceuticals

Select article: Human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer: how the latest results are improving therapeutic options

Free access

Review article

First published 2015-11

Human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer: how the latest results are improving therapeutic options

Hanfang Jiang, Hope S. Rugo

Therapeutic Advances in Medical Oncology

Select article: Systematic Review: Targeting HER2 in Bladder Cancer

Open access

Review article

First published 2019

Systematic Review: Targeting HER2 in Bladder Cancer

Vadim S. Koshkin, Peter O’Donnell, Evan Y. Yu [...]

Bladder Cancer

Select article: Targeted gold nanoshelled hybrid nanocapsules encapsulating doxorubicin for bimodal imaging and near-infrared triggered synergistic therapy of Her2-positve breast cancer

Retricted access

Research article

First published 2020-9

Targeted gold nanoshelled hybrid nanocapsules encapsulating doxorubicin for bimodal imaging and near-infrared triggered synergistic therapy of Her2-positve breast cancer

Qi Dong, Caifeng Wan, Hong Yang [...]

Journal of Biomaterials Applications

Select article: Improving survival and limiting toxicity: latest advances in treating human epidermal growth factor receptor 2 overexpressing breast cancer

Free access

Review article

First published 2012-5

Improving survival and limiting toxicity: latest advances in treating human epidermal growth factor receptor 2 overexpressing breast cancer

Vandana G. Abramson, Ingrid A. Mayer

Therapeutic Advances in Medical Oncology

Select article: Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations

Open access

Review article

First published 2012

Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations

Alwin Jeyakumar, Tallal Younis

Clinical Medicine Insights: Oncology

Select article: Emerging Antibody-Based HER2 (ErbB-2/neu) Therapeutics

Free access

Research article

First published 2000-6-1

Emerging Antibody-Based HER2 (ErbB-2/neu) Therapeutics

W.C. Krauss, J.W. Park, D.B. Kirpotin [...]

Breast Disease

Select article: Therapeutic Landscape of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Open access

Review article

First published 2022-04

Therapeutic Landscape of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Jindong Xie, Yutian Zou, Ting Gao [...]

Cancer Control

Select article: Pertuzumab in Combination with Trastuzumab and Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Safety,Efficacy,and Progression Free Survival

Open access

Review article

First published 2014

Pertuzumab in Combination with Trastuzumab and Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Safety,Efficacy,and Progression Free Survival

Joseph J. Maly, Erin R. Macrae

Breast Cancer: Basic and Clinical Research

1
2
3
•••
9
10 / page

Article type

Publication date

Subjects

Access